The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma

被引:11
|
作者
Zhang, Jie [1 ]
Shi, Keqing [2 ]
Huang, Weiguo [1 ]
Weng, Wanqing [1 ]
Zhang, Zhongjing [1 ]
Guo, Yangyang [1 ]
Deng, Tuo [1 ]
Xiang, Yukai [1 ]
Ni, Xiaofeng [1 ]
Chen, Bicheng [1 ]
Zhou, Mengtao [1 ,2 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou 325015, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Precis Med Ctr, Affiliated Hosp 1, Wenzhou 325015, Zhejiang, Peoples R China
关键词
DNA methylation; Pancreatic adenocarcinoma; miRNA; lncRNA; Classifier; Prognosis; GASTRIC-CANCER; PROMOTES; EXPRESSION; CELLS; MAPK;
D O I
10.1186/s12935-019-0828-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCompelling lines of evidence indicate that DNA methylation of non-coding RNAs (ncRNAs) plays critical roles in various tumour progression. In addition, the differential methylation of ncRNAs can predict prognosis of patients. However, little is known about the clear relationship between DNA methylation profile of ncRNAs and the prognosis of pancreatic adenocarcinoma (PAC) patients.MethodsThe data of DNA methylation, RNA-seq, miRNA-seq and clinical features of PAC patients were collected from TCGA database. The DNA methylation profile was obtained using the Infinium HumanMethylation450 BeadChip array. LASSO regression was performed to construct two methylation-based classifiers. The risk score of methylation-based classifiers was calculated for each patient, and the accuracy of the classifiers in predicting overall survival (OS) was examined by ROC curve analysis. In addition, Cox regression models were utilized to assess whether clinical variables and the classifiers were independent prognostic factors for OS. The targets of miRNA and the genes co-expressed with lncRNA were identified with DIANA microT-CDS and the Multi-Experiment Matrix (MEM), respectively. Moreover, DAVID Bioinformatics Resources were applied to analyse the functional enrichment of these targets and co-expressed genes.ResultsA total of 4004 CpG sites of miRNA and 11,259 CpG sites of lncRNA were screened. Among these CpG sites, 8 CpG sites of miRNA and 7 CpG sites of lncRNA were found with regression coefficients. By multiplying the sum of methylation degrees of the selected CpGs with these coefficients, two methylation-based classifiers were constructed. The classifiers have shown good performance in predicting the survival rate of PAC patients at varying follow-up times. Interestingly, both of these two classifiers were predominant and independent factors for OS. Furthermore, functional enrichment analysis demonstrated that aberrantly methylated miRNAs and lncRNAs are related to calcium ion transmembrane transport and MAPK, Ras and calcium signalling pathways.ConclusionIn the present study, we identified two methylation-based classifiers of ncRNA associated with OS in PAC patients through a comprehensive analysis of miRNA and lncRNA profiles. We are the first group to demonstrate a relationship between the aberrant DNA methylation of ncRNAs and the prognosis of PAC, and this relationship would contribute to individualized PAC therapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
    Jie Zhang
    Keqing Shi
    Weiguo Huang
    Wanqing Weng
    Zhongjing Zhang
    Yangyang Guo
    Tuo Deng
    Yukai Xiang
    Xiaofeng Ni
    Bicheng Chen
    Mengtao Zhou
    Cancer Cell International, 19
  • [2] Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
    Gong, Ruining
    Jiang, Yueping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Non-coding RNAs and DNA methylation in plants
    Yuanyuan Zhao
    Xuemei Chen
    NationalScienceReview, 2014, 1 (02) : 219 - 229
  • [4] Non-coding RNAs and DNA methylation in plants
    Zhao, Yuanyuan
    Chen, Xuemei
    NATIONAL SCIENCE REVIEW, 2014, 1 (02) : 219 - 229
  • [5] Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma
    Zhou, Yu
    Gong, Bo
    Jiang, Zhi-Lin
    Zhong, Shan
    Liu, Xing-Chao
    Dong, Ke
    Wu, He-Shui
    Yang, Hong-Ji
    Zhu, Shi-Kai
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 670 - 680
  • [6] Prediction of overall survival time in patients with colon adenocarcinoma using DNA methylation profiling of long non-coding RNAs
    Zhang, Qiongying
    Lin, Zhuo
    Zhang, Haiyan
    Bao, Xiaodong
    Zhang, Huxiang
    ONCOLOGY LETTERS, 2020, 19 (02) : 1496 - 1504
  • [7] A ROLE FOR DNA METHYLATION IN REGULATING MACRO NON-CODING RNAS
    Vlatkovic, Irena
    Huang, Ru
    Rudigier, Lucas J.
    Pauler, Florian M.
    Sloane, Mathew A.
    Barlow, Denise P.
    CELLULAR ONCOLOGY, 2009, 31 (02) : 115 - 115
  • [8] A DNA methylation profile of long non-coding RNAs can predict OS in prostate cancer
    Cheng, Wei
    Cao, Jie
    Xia, Yong
    Lei, Xin
    Wu, Lili
    Shi, Liang
    BIOENGINEERED, 2021, 12 (01) : 3252 - 3262
  • [9] DNA methylation and long non-coding RNA in lung adenocarcinoma
    Ahn, S.
    Pyo, J. Y.
    Song, J.
    Lee, Y. J.
    VIRCHOWS ARCHIV, 2019, 475 : S135 - S135
  • [10] Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma
    Dubaj, Maciej
    Bigosinski, Karol
    Dembowska, Aleksandra
    Mlak, Radoslaw
    Szudy-Szczyrek, Aneta
    Malecka-Massalska, Teresa
    Homa-Mlak, Iwona
    CANCERS, 2024, 16 (05)